Home
Cormorant Asset Management reported a 4.35% stake in MoonLake Immunotherapeutics MLTX · 3,205,433 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.35%
- Last report
- 6.25% · filed 26/05/15
- Shares held
- 3,205,433 sh
- Class
- Class A ordinary share, par value $0.0001 per share
- Event date
- 26/06/30
- Filed
- 26/08/14
4.35% stake · below 5%
- Stake
- 4.35%
- Last report
- 6.25%
- Since last report
- −1.9pp
MoonLake Immunotherapeutics trades, last 26 weeks
What else happened in MoonLake Immunotherapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Cormorant Asset Management's other 5% stake reports
- Cormorant Asset Management
5% stakeRallybio
5% stakeRallybio
RLYB
0% stake
0 sh
0% stake
Filed 08/14
- Cormorant Asset Management
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
9.99% stake
108,029 sh
9.99% stake
Filed 08/14
- Cormorant Asset Management
5% stakeEyePoint
5% stakeEyePoint
EYPT
8.35% stake
7,000,000 sh
8.35% stake
Filed 08/14
- Cormorant Asset Management
5% stakeCabaletta Bio
5% stakeCabaletta Bio
CABA
5.95% stake
10,000,000 sh
5.95% stake
Filed 08/14
- Cormorant Asset Management
5% stakeBioAge Labs
5% stakeBioAge Labs
BIOA
5.38% stake
2,390,605 sh
5.38% stake
Filed 08/14
